These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
41 related items for PubMed ID: 21551887
1. Autoradiographic analysis of muscarinic receptors and choline-uptake mechanisms within foetal basal forebrain transplants. Sharkey J, Kelly PA. Restor Neurol Neurosci; 1992 Jan 01; 3(6):293-300. PubMed ID: 21551887 [Abstract] [Full Text] [Related]
3. Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study. Lowenstein PR, Slesinger PA, Singer HS, Walker LC, Casanova MF, Raskin LS, Price DL, Coyle JT. J Comp Neurol; 1989 Oct 15; 288(3):428-46. PubMed ID: 2794143 [Abstract] [Full Text] [Related]
4. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes. Burke RE. Mol Pharmacol; 1986 Jul 15; 30(1):58-68. PubMed ID: 3755217 [Abstract] [Full Text] [Related]
5. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies. Araujo DM, Lapchak PA, Quirion R. Synapse; 1991 Nov 15; 9(3):165-76. PubMed ID: 1776129 [Abstract] [Full Text] [Related]
6. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. Norman AB, Eubanks JH, Creese I. J Pharmacol Exp Ther; 1989 Mar 15; 248(3):1116-22. PubMed ID: 2703964 [Abstract] [Full Text] [Related]
7. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. Rossner S, Schliebs R, Perez-Polo JR, Wiley RG, Bigl V. J Neurosci Res; 1995 Jan 01; 40(1):31-43. PubMed ID: 7714924 [Abstract] [Full Text] [Related]
8. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart. Evans RA, Watson M, Yamamura HI, Roeske WR. J Pharmacol Exp Ther; 1985 Dec 01; 235(3):612-8. PubMed ID: 3841156 [Abstract] [Full Text] [Related]
9. Characterization and autoradiographic distribution of hemicholinium-3 high-affinity choline uptake sites in mammalian brain. Quirion R. Synapse; 1987 Dec 01; 1(4):293-303. PubMed ID: 3138770 [Abstract] [Full Text] [Related]
11. Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on striatal muscarinic cholinergic receptors and high-affinity choline uptake sites: a quantitative autoradiographic study. Kostic V, Przedborski S, Jackson-Lewis V, Cadet JL, Burke RE. J Neurochem; 1991 Dec 01; 57(6):1962-70. PubMed ID: 1940912 [Abstract] [Full Text] [Related]
12. Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart. Luthin GR, Harkness J, Artymyshyn RP, Wolfe BB. Mol Pharmacol; 1988 Sep 01; 34(3):327-33. PubMed ID: 3419425 [Abstract] [Full Text] [Related]
13. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1984 Mar 01; 228(3):648-55. PubMed ID: 6546770 [Abstract] [Full Text] [Related]
14. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain. Luthin GR, Wolfe BB. J Pharmacol Exp Ther; 1985 Jul 01; 234(1):37-44. PubMed ID: 3839265 [Abstract] [Full Text] [Related]
15. Development of markers for cholinergic neurones in re-aggregate cultures of foetal rat whole brain in serum-containing and serum-free media: effects of triiodothyronine (T3). Atterwill CK, Kingsbury A, Nicholls J, Prince A. Br J Pharmacol; 1984 Sep 01; 83(1):89-102. PubMed ID: 6487898 [Abstract] [Full Text] [Related]
16. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB, Creese I. Mol Pharmacol; 1986 Aug 01; 30(2):96-103. PubMed ID: 3755499 [Abstract] [Full Text] [Related]
17. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. Watson M, Roeske WR, Yamamura HI. J Pharmacol Exp Ther; 1986 May 01; 237(2):419-27. PubMed ID: 3754581 [Abstract] [Full Text] [Related]
18. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Dunlap J, Brown JH. Mol Pharmacol; 1983 Jul 01; 24(1):15-22. PubMed ID: 6135150 [Abstract] [Full Text] [Related]
19. Regulation of muscarinic receptor subtypes and their responsiveness in rat brain following chronic atropine administration. Lee W, Wolfe BB. Mol Pharmacol; 1989 Nov 01; 36(5):749-57. PubMed ID: 2555673 [Abstract] [Full Text] [Related]
20. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung. Bloom JW, Halonen M, Lawrence LJ, Rould E, Seaver NA, Yamamura HI. J Pharmacol Exp Ther; 1987 Jan 01; 240(1):51-8. PubMed ID: 3806397 [Abstract] [Full Text] [Related] Page: [Next] [New Search]